Literature DB >> 3095914

ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases.

T B Halvorsen.   

Abstract

The distribution of ABO blood groups and Rh types was studied retrospectively in 747 patients with single adenocarcinomas of the large intestine. The distributions were similar to those of healthy blood donors. Rh- patients had a more favourable stage distribution than Rh+ patients. The proportion of patients with localized disease was higher for Rh- patients than for Rh+ patients (66% versus 46%), whereas metastases into regional lymph nodes were more common among Rh+ patients (23% versus 9%). The observed relationship between Rh type and stage distribution suggests that Rh+ patients with colorectal cancer are less protected against tumour spread than Rh- patients, especially with regard to regional lymph node metastases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3095914     DOI: 10.3109/00365528608996408

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  ABO blood group and risk of colorectal cancer.

Authors:  Hamed Khalili; Brian M Wolpin; Edward S Huang; Edward L Giovannucci; Peter Kraft; Charles S Fuchs; Andrew T Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

2.  Is there a predictive significance of ABO blood group on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer?

Authors:  Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

Review 3.  Current status of tumor markers in large bowel cancer.

Authors:  M Moore; D J Jones; P F Schofield; D G Harnden
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

Review 4.  The role of the histoblood ABO group in cancer.

Authors:  Seth K Rummel; Rachel E Ellsworth
Journal:  Future Sci OA       Date:  2016-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.